Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
Hound Partners 6.98M $298.48M Dec. 31, 2015
OrbiMed Advisors 6.66M $284.96M Dec. 31, 2015
BlackRock Fund Advisors 5.48M $234.50M Dec. 31, 2015
Vanguard 5.18M $221.46M Dec. 31, 2015
Inves 3.53M $150.89M Dec. 31, 2015
Visium Asset Management 3.40M $52.50M March 31, 2013
ARAVT GLOBAL 3.07M $131.35M Dec. 31, 2015
Wells Fargo & Company 2.71M $55.10M June 30, 2012
TCW 2.68M $54.41M June 30, 2012
CITADEL ADVISORS 2.47M $38.20M March 31, 2013
Franklin Resources 2.47M $105.78M Dec. 31, 2015
RS INVESTMENT MANAGEMENT 2.35M $59.09M Dec. 31, 2013
Pennant Capital Management 2.32M $99.27M Dec. 31, 2015
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
Ameriprise Financial 2.09M $42.84M Sept. 30, 2013
FMR 1.87M $87.85M March 31, 2015
STATE STREET CORPORATION 1.85M $79.00M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 1.81M $84.70M March 31, 2015
Jennison Associates 1.72M $51.63M June 30, 2014

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
ALLIANCEBERNSTEIN June 30, 2011 1.81M $39.38M
FRIESS ASSOCIATES March 31, 2011 2.19M $55.70M